Stephen Johnson

Array ( [id] => 9122166 [patent_doc_number] => 20130289088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR LOWERING INTRAOCULAR PRESSURE' [patent_app_type] => utility [patent_app_number] => 13/916888 [patent_app_country] => US [patent_app_date] => 2013-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10577 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13916888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9384700 [patent_doc_number] => 20140088182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-27 [patent_title] => 'INFLAMMATORY EYE DISEASE' [patent_app_type] => utility [patent_app_number] => 13/916207 [patent_app_country] => US [patent_app_date] => 2013-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7389 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13916207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9042341 [patent_doc_number] => 20130244978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-19 [patent_title] => 'OPHTHALMIC COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/889576 [patent_app_country] => US [patent_app_date] => 2013-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14714 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13889576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9069434 [patent_doc_number] => 20130261190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-03 [patent_title] => 'Ophthalmic Compositions with Biguanide and PEG-Glycerol Esters' [patent_app_type] => utility [patent_app_number] => 13/886571 [patent_app_country] => US [patent_app_date] => 2013-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7586 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13886571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9134361 [patent_doc_number] => 20130295075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'COMPOSITIONS AND METHODS OF TREATING GLAUCOMA' [patent_app_type] => utility [patent_app_number] => 13/887217 [patent_app_country] => US [patent_app_date] => 2013-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 9842 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13887217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9055283 [patent_doc_number] => 20130252997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-26 [patent_title] => 'TREATING UNWANTED OCULAR CONDITION USING AN ASCOMYCIN MACROLACTAM' [patent_app_type] => utility [patent_app_number] => 13/887057 [patent_app_country] => US [patent_app_date] => 2013-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3999 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13887057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9162143 [patent_doc_number] => 20130310420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-21 [patent_title] => 'STABLE FORMULATIONS OF PITAVASTATIN' [patent_app_type] => utility [patent_app_number] => 13/865118 [patent_app_country] => US [patent_app_date] => 2013-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4380 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13865118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16040939 [patent_doc_number] => 10682320 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-16 [patent_title] => Method for inhibiting osteoclast development [patent_app_type] => utility [patent_app_number] => 13/864438 [patent_app_country] => US [patent_app_date] => 2013-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 7942 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13864438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9281330 [patent_doc_number] => 20140031298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-30 [patent_title] => 'Compositions and Methods for Localized Therapy of the Eye' [patent_app_type] => utility [patent_app_number] => 13/857707 [patent_app_country] => US [patent_app_date] => 2013-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7252 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13857707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8854283 [patent_doc_number] => 20130143958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'DOSAGE UNIT COMPRISING A PROSTAGLANDIN ANALOG FOR TREATING CONSTIPATION' [patent_app_type] => utility [patent_app_number] => 13/754138 [patent_app_country] => US [patent_app_date] => 2013-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4651 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13754138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8842023 [patent_doc_number] => 20130137651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-30 [patent_title] => 'GEL USEFUL FOR THE DELIVERY OF OPHTHALMIC DRUGS' [patent_app_type] => utility [patent_app_number] => 13/749790 [patent_app_country] => US [patent_app_date] => 2013-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4795 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13749790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9019933 [patent_doc_number] => 08529916 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-10 [patent_title] => 'High concentration baclofen preparations' [patent_app_type] => utility [patent_app_number] => 13/743081 [patent_app_country] => US [patent_app_date] => 2013-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7141 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13743081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8892296 [patent_doc_number] => 20130165480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'Stabilized and Preserved Ketotifen Ophthalmic Compositions' [patent_app_type] => utility [patent_app_number] => 13/739060 [patent_app_country] => US [patent_app_date] => 2013-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2481 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13739060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9281465 [patent_doc_number] => 20140031433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-30 [patent_title] => 'FORMULATIONS OF TOCOTRIENOL QUINONES FOR THE TREATMENT OF OPHTHALMIC DISEASES' [patent_app_type] => utility [patent_app_number] => 13/738827 [patent_app_country] => US [patent_app_date] => 2013-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21470 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13738827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8817463 [patent_doc_number] => 20130118508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-16 [patent_title] => 'PLUG FOR BLOCKAGE OF THE CANALICULUS' [patent_app_type] => utility [patent_app_number] => 13/733811 [patent_app_country] => US [patent_app_date] => 2013-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5586 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13733811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8822266 [patent_doc_number] => 20130123312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-16 [patent_title] => 'Compositions and Methods of Using R(+) Pramipexole' [patent_app_type] => utility [patent_app_number] => 13/722487 [patent_app_country] => US [patent_app_date] => 2012-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19087 [patent_no_of_claims] => 86 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13722487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8815197 [patent_doc_number] => 20130116242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'METHOD OF TREATMENT OF HORMONE DEPLETION INDUCED VASOMOTOR' [patent_app_type] => utility [patent_app_number] => 13/722507 [patent_app_country] => US [patent_app_date] => 2012-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2128 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13722507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8951169 [patent_doc_number] => 20130196950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'RETINOID REPLACEMENTS AND OPSIN AGONISTS AND METHODS FOR THE USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/708558 [patent_app_country] => US [patent_app_date] => 2012-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21622 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13708558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8951169 [patent_doc_number] => 20130196950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'RETINOID REPLACEMENTS AND OPSIN AGONISTS AND METHODS FOR THE USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/708558 [patent_app_country] => US [patent_app_date] => 2012-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21622 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13708558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9703973 [patent_doc_number] => 08829037 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'Optical correction' [patent_app_type] => utility [patent_app_number] => 13/692257 [patent_app_country] => US [patent_app_date] => 2012-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3035 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13692257 [rel_patent_id] =>[rel_patent_doc_number] =>)